Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950123-09-064675
Filing Date
2009-11-20
Accepted
2009-11-20 14:41:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b78160e8vk.htm 425 9156
2 EX-99.1 PRESS RELEASE DATED NOVEMBER 17, 2009 b78160exv99w1.htm EX-99.1 12139
3 GRAPHIC b78160b7816001.gif GRAPHIC 4893
  Complete submission text file 0000950123-09-064675.txt   30157
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filed by) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080
Business Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Subject) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-26483 | Film No.: 091198282
SIC: 2834 Pharmaceutical Preparations